Omega-3 (n-3) Fatty Acid–Statin Interaction: Evidence for a Novel Therapeutic Strategy for Atherosclerotic Cardiovascular Disease

I Djuricic, PC Calder - Nutrients, 2024 - mdpi.com
Managing atherosclerotic cardiovascular disease (ASCVD) often involves a combination of
lifestyle modifications and medications aiming to decrease the risk of cardiovascular …

Closing the gaps in patient management of dyslipidemia: stepping into cardiovascular precision diagnostics with apolipoprotein profiling

E Reijnders, A van der Laarse, LR Ruhaak… - Clinical Proteomics, 2024 - Springer
In persons with dyslipidemia, a high residual risk of cardiovascular disease remains despite
lipid lowering therapy. Current cardiovascular risk prediction mainly focuses on low-density …

The effect of lipid-lowering therapy on lipid-related residual risk factors: a prospective study

Z Li, Y Gao, Q Lu, Z Yin, S Zhang, W Zhang… - Lipids in Health and …, 2024 - Springer
Background Remnant cholesterol (RC) and nonhigh-density lipoprotein cholesterol
(nonHDL-C) are key risk factors for atherosclerotic cardiovascular disease (ASCVD), with …

Evolving Concepts of the SCORE System: Subtracting Cholesterol from Risk Estimation: A Way for a Healthy Longevity?

F Natale, R Franzese, L Marotta, N Mollo, A Solimene… - Life, 2024 - mdpi.com
The role of cholesterol, mainly low-density lipoproteins (LDL-C), as a causal risk factor for
atherosclerotic cardiovascular disease (ASCVD) is now established and accepted by the …

Bibliometric analysis of residual cardiovascular risk: trends and frontiers

L Wang, S Wang, C Song, Y Yu, Y Jiang… - Journal of Health …, 2023 - Springer
Background The presence of residual cardiovascular risk is an important cause of
cardiovascular events. Despite the significant advances in our understanding of residual …

Quality Assurance for Multiplex Quantitative Clinical Chemistry Proteomics in Large Clinical Trials

E Reijnders, FP Romijn, F Arslan… - The Journal of …, 2024 - academic.oup.com
Background To evaluate the clinical performance and effectiveness of a multiplex
apolipoprotein panel in the context of cardiovascular precision diagnostics, clinical samples …